November 10, 2022
Video
Matthew P. Goetz, MD, discusses the background of the ELAINE-1 study examining lasofoxifene in patients with estrogen receptor-positive, HER2-negative metastatic breast cancer harboring estrogen receptor 1 mutations.
October 10, 2022
Video
Matthew P. Goetz, MD, discusses recent data on estrogen receptor mutations in patients with breast cancer.
January 25, 2018
Video
Matthew Goetz, MD, professor of oncology and pharmacology, Mayo Clinic, discusses a secondary analysis of the MONARCH 1 and MONARCH 2 clinical trials in breast cancer.